7月1日,我院介入放射科張應(yīng)強醫(yī)生、腫瘤科汪波主任團隊及中山一院腫瘤介入團隊在Journal of Vascular and Interventional Radiology,JVIR期刊上發(fā)表了研究性論文“Gefitinib with or without transarterial infusion chemotherapy (cisplatin) for large non-small cell lung cancer with epidermal growth factor receptor mutations”。